Edegem

• Safety of Anumigilimab (CSL324) in Adults with Sickle Cell Disease Pending
  2025-521154-42-00 4 Sickle Cell Disease
• Extension Study of ADX-324 in Hereditary angioedema Pending
  2025-521353-16-00 5 Hereditary Angioedema
• An autologous and antigen-specific cell-based therapy of vitamin D3-treated and myelin-derived peptide loaded tolerogenic dendritic cells in … Pending
  2025-522040-40-01 4 Multiple Sclerosis
• Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV immunisation adaptive platform trial (PIPELINE-RSV) Pending
  2025-522194-11-00 5 Respiratory Syncytial Virus (RSV)
• The use of intranasal dexmedetomidine for pediatric sedation in non-invasive radiological procedures Pending
  2025-522778-34-00 4 Sedation in healthy children
• A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L … Pending
  2025-522818-23-00 5 Small Cell Lung Cancer (SCLC)
• A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies Pending
  2025-523130-11-00 1 Hematological malignancies
• A study to learn if fenfluramine hydrochloride is safe and works in people with Rett syndrome Pending
  2025-523157-34-00 5 Rett syndrome
• A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3 … Pending
  2025-523674-16-00 5 Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F … Pending
  2025-523675-39-00 5 Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 Metastatic Microsatellite Stable Colorectal Cancer
• Efficacy and safety of vamifeport in adult subjects with HFE-related hereditary hemochromatosis Pending
  2025-523793-16-00 4 Homeostatic iron regulator gene-related hereditary hemochromatosis
• Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome Pending
  2025-523835-20-00 7 Dravet Syndrome
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending
  2025-523911-13-00 5 Narcolepsy Type 1
• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 Pending
  2025-523912-35-00 5 Narcolepsy Type 2
• A study on the safety of and immune response to different doses of RSV/hMPV combination and hMPV vaccines in adults Pending
  2025-524456-58-00 7 Respiratory Syncytial Virus Infections+Metapneumovirus
• A Research Study Testing New Cancer Medicines Used Alone or Together to Treat Solid Tumors Pending
  2025-524623-50-00 9 Solid Tumors
• ENDO-REAL: Endometriosis and Reproductive Enhancement with Letrozole Pending
  2025-524995-53-00 6 Women with endometriosis undergoing IVF/ICSI
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• Randomized Evaluation of fleCAinide safety vs. STandard of care in patients with coronary artery disease and Atrial Fibrillation (ReCAST AF) … Pending
  2025-525121-13-00 6 Coronary artery disease
• Relative bioavailability and effect of food study with GLPG3667 in healthy subjects Pending
  2026-525706-35-00 3 inflammatory and autoimmune diseases
• A Trial to Evaluate the Safety and Drug Levels of Single and Multiple Oral Doses of AT-587 in Healthy Adults Pending
  2026-526237-26-00 1 Chronic hepatitis E virus (HEV) infection
• A study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with IV Bevacizumab Compared to Standard of Care IV Bevacizumab i … Recruiting
  2025-521712-19-00 5 2026-07-06 Colorectal Cancer

Showing 25–48 of 590 trials